EUVIMEDEUVIMED entdecken
Crossref

Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model

Zirui Zhao, Lei Han, Zhijiao Xu, Benyu Nan, Honghai Tang, Dingding Dong, Zhen Zen, Ziwen Gao, Cheng Ye, Xinsheng Huang, Jianning Zhang, Geng-Lin Li und 1 weitere

Archives of Toxicology · 2026

DOI: 10.1007/s00204-026-04410-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Zirui Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. Hauptthemen laut MEDLINE: Cisplatin, Ototoxicity, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Innovative Research Group Project of the National Natural Science Foundation of China, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinOtotoxicityAntineoplastic AgentsBreast NeoplasmsHearing LossAnimalsFemaleMiceCell Line, TumorHumansApoptosis

Stichwörter der Autor:innen

Anti-apoptosisCancerOtotoxicitySchizantherin B

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
  • Institute of Biomedical Science, Fudan University, Shanghai, 200031, China.
  • NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai, 200031, China.
  • Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, 200031, China.
  • State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200031, China.
  • Department of Otolaryngology, Yueyang Hospital of Integrative Chinese & Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.

ORCID-Profile: Yilai Shu

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Education Commission
  • Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province
  • Ministry of Science and Technology of the People’s Republic of China

Zitieren

APA

Zhao, Z., Han, L., Xu, Z., Nan, B., Tang, H., Dong, D., Zen, Z., Gao, Z., Ye, C., Huang, X., Zhang, J., Li, G. L., & Shu, Y. (2026). Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04410-2

Vancouver

Zhao Z, Han L, Xu Z, Nan B, Tang H, Dong D, et al. Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04410-2

BibTeX
@article{Zhao2026,
  author = {Zhao, Zirui and Han, Lei and Xu, Zhijiao and Nan, Benyu and Tang, Honghai and Dong, Dingding and Zen, Zhen and Gao, Ziwen and Ye, Cheng and Huang, Xinsheng and Zhang, Jianning and Li, Geng-Lin and Shu, Yilai},
  title = {Schizantherin B alleviates cisplatin-induced ototoxicity and does not interfere cisplatin-based chemotherapy in a breast cancer model},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-026-04410-2}
}
Kostenlos starten →